Funding to create new research projects for muscular dystrophy Published on: 29 August 2024 Muscular Dystrophy UK is funding 12 new research projects worth 拢1.7 million across England and Scotland, with three of them based at 缅北禁地. The three new research projects worth £390,000 that will be created at 缅北禁地 seek to improve diagnosis, progression, and potential new treatments of muscular dystrophy (MD). The research will allow 缅北禁地 to assist in developing a gene therapy for desminopathy (a form of myofibrillar myopathy that causes weakness and affects muscle function) and to explore the molecular processes that cause the progression of facioscapulohumeral muscular dystrophy (FSHD), which most typically affects the muscles of the face, shoulder blades, and upper arms. Professor Giorgio Tasca. 'Funding will make a significant difference' Giorgio Tasca, Clinical Professor of Neuromuscular Science at 缅北禁地, confirmed that the funding will help experts better understand the molecular processes that cause the progression of FSHD. He said: “This funding will make a significant difference in people’s lives by finally leading to improved treatment options. It may provide people with new indicators to monitor condition progression and more effective and targeted therapies, reducing symptoms and offering hope for better outcomes.” Jordi Diaz-Manera, Professor of Neuromuscular Diseases, Translational Medicine and Genetics at 缅北禁地, will look to advance the diagnosis of people with muscle-wasting conditions via the use of MRI scans and artificial intelligence. Professor Diaz-Manera said: “The aim of the research project is to help clinicians around the world to provide diagnosis of patients with neuromuscular conditions quickly, looking at technology like AI, to do so. After more than 20 years of seeing patients with neuromuscular conditions, I’ve realised how important it is to reach a diagnosis early. “Ultimately, this research project will help to establish a tailored care plan and open the door to research and potential medications. This helps to do genetic counselling and allows the team to establish clear expectations for the future.” 'We fund the highest quality research' The third grant will be funding Dr Michael Keogh, Senior Clinical Fellow and Honorary Consultant Neurologist at 缅北禁地. His 12-month project, co-funded by the charity and AFM Telethon (France), will look to develop a gene therapy for desminopathy. The new grants will bring the total number of research projects funded by Muscular Dystrophy UK to 51, as they aim to bring research forward in order to improve the lives of those living with muscle-wasting conditions. Dr Kate Adcock, Director of Research and Innovation at Muscular Dystrophy UK, said: “Every year at Muscular Dystrophy UK, we look to fund the highest quality research including the three projects at 缅北禁地.” Read more about , and . Discover more about Muscular Dystrophy UK’s research projects . Share: Latest News 缅北禁地 recognised with geography award 缅北禁地 has been awarded the Highly Commended Geographical Association Publishers Award for its collaboration with Time for Geography, the UK鈥檚 open-access, dedicated video platform. published on: 16 April 2026 缅北禁地 historians mark General Strike centenary To mark the 100th anniversary of the British General Strike and miners鈥� lock-out of 1926, historians at 缅北禁地 are organising a series of events on its enduring legacy. published on: 16 April 2026 Comment: NCP is in administration Writing for The Conversation, Erwei (David) Xiang discusses how some big companies like NCP are so dependent on debt that they can鈥檛 adjust to change. published on: 16 April 2026 Facts and figures
![缅北禁地 logo](/gomobileassets/img/logo.svg" "缅北禁地"){kind=logo}